- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hepatocellular Cancer in Hong Kong
Total 1118 results
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Hong Kong, Taiwan, Singapore
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersTaiwan, Hong Kong, Japan
-
Yiviva Inc.RecruitingAdvanced Hepatocellular CarcinomaUnited States, Taiwan, China, Hong Kong
-
University of WashingtonNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Cervical Undifferentiated Carcinoma | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage... and other conditionsUnited States, Hong Kong, Canada
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Taiwan, Germany, Italy, Hong Kong, Canada, Japan, Spain
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaChina, Taiwan, Thailand, Korea, Republic of, Hong Kong
-
Hoffmann-La RocheCompletedNasopharyngeal CancerHong Kong, Thailand, Indonesia, Taiwan, Malaysia
-
TularikUnknownHepatocellular CarcinomaUnited States, China
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
Novartis PharmaceuticalsCompletedAdvanced Hepatocellular CarcinomaTaiwan, Canada, Italy, Korea, Republic of, Hong Kong, Germany, China, France
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Taiwan, Korea, Republic of, Singapore
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedGastric CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
National Medical Research Council (NMRC), SingaporeCompletedLiver CancerNew Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
-
GC Cell CorporationCompletedHepatocellular CarcinomaKorea, Republic of
-
National Cancer Centre, SingaporeSingapore General HospitalRecruitingNon-Small Cell Lung Cancer | Lung CancerThailand, Singapore, Hong Kong, Brunei Darussalam, India, Malaysia
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Cullinan Oncology, LLCNational Cancer Institute (NCI)TerminatedNasopharyngeal Carcinoma | Nasopharyngeal CancerFrance, Singapore, United States, China, Hong Kong
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Proacta, IncorporatedTerminatedHepatocellular CarcinomaUnited States, Taiwan, Singapore, Hong Kong
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Broncus Medical IncCompletedLung CancerUnited States, China, Germany, Hong Kong
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Uppsala UniversityBaylor College of Medicine; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsRecruitingBreast Cancer | Breast Neoplasms | Sentinel Lymph Node | DCISUnited States, Sweden, Hong Kong
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
AstraZenecaCompletedHepatocellular CarcinomaKorea, Republic of, Russian Federation, Hong Kong, Egypt, Saudi Arabia, United Arab Emirates, Singapore, India, Kuwait, Oman, Brazil
-
National Hospital Organization Nagoya Medical CenterRecruitingAcute Lymphoblastic Leukemia | Down Syndrome | Childhood CancerTaiwan, Thailand, Hong Kong, Singapore, Malaysia, Japan
-
PfizerTerminatedBreast CancerUnited States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaTaiwan, Hong Kong, China, Thailand, Korea, Republic of, Singapore, Japan
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
ASLAN PharmaceuticalsCompletedMetastatic Breast CancerAustralia, Hong Kong, Korea, Republic of, New Zealand, Philippines, Singapore, Taiwan
-
FeRxTerminatedCarcinoma, HepatocellularUnited States, Austria, Thailand, Germany, Ukraine, United Kingdom, Hong Kong, Russian Federation
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingAdvanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States, Canada, Australia, Hong Kong, Korea, Republic of
-
Zai Lab (Shanghai) Co., Ltd.TerminatedGastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract CarcinomaChina
-
Singapore General HospitalNational Cancer Centre, Singapore; National Medical Research Council (NMRC)... and other collaboratorsUnknownHepatocellular CarcinomaTaiwan, Korea, Republic of, Malaysia, New Zealand, Philippines, Singapore, China, Thailand, Brunei Darussalam, Indonesia, Mongolia, Myanmar
-
Novartis PharmaceuticalsCompletedMelanoma | CancerTaiwan, Thailand, China, Hong Kong, Korea, Republic of
-
Taiho Pharmaceutical Co., Ltd.TerminatedHead and Neck CancerUnited States, Hong Kong, Singapore, Taiwan
-
Novartis PharmaceuticalsCompletedHepatocellular Carcinoma (HCC) | Solid MalignanciesUnited States, Germany, Taiwan, Spain, Singapore, France, Japan, Korea, Republic of, Hong Kong, China, Italy
-
National Cancer Centre, SingaporeIqvia Pty Ltd; Singapore Clinical Research Institute; Asia-Pacific Hepatocellular...CompletedHepatocellular CarcinomaChina, Korea, Republic of, Taiwan, Australia, Hong Kong, Singapore, New Zealand, Japan, Thailand
-
BayerCompletedCarcinoma, HepatocellularJapan, Turkey, Austria, Czechia, Hungary, Israel, Russian Federation, Slovakia, Switzerland, India, Korea, Republic of, France, Mexico, Indonesia, Singapore, Thailand, Canada, Greece, Netherlands, Spain, Taiwan, Poland, Brazil, China, D... and more
-
Astellas Pharma Global Development, Inc.PfizerCompletedAdvanced Hepatocellular CarcinomaCanada, United States, Hong Kong, Italy, Korea, Republic of, Puerto Rico, Spain, Taiwan, United Kingdom
-
Bristol-Myers SquibbCompletedHepatocellular Carcinoma (HCC)France, Korea, Republic of, Taiwan, United States, Singapore, Philippines, Malaysia, Hong Kong
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Triple Negative Breast Cancer | Microsatellite Stable Colorectal CancerUnited States, Taiwan, Spain, Germany, Japan, Hong Kong
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerHong Kong, Taiwan, Philippines, China, Thailand, Indonesia, Australia, Korea, Republic of
-
Astellas Pharma IncTerminatedAdvanced Hepatocellular Carcinoma (HCC)Korea, Republic of, Belgium, United States, Hong Kong, Singapore, Taiwan, Germany, Spain, France, Italy
-
AstraZenecaTerminated
-
AstraZenecaRecruitingAdvanced Hepatocellular CarcinomaKorea, Republic of, Italy, Spain, Vietnam, Germany, France, Japan, United States, Hong Kong, Singapore